Minutia
Pioneering a functional cure for T1D which can replace all these injections with one simple implant in the forearm.
* Data source: Crunchbase
- Founded
- 2021
- Employees*
- 11
- Funding to Date*
- $6,500,000
- Website
- www.minutia.co
"Developing a functional cure for type 1 diabetes using a simple out-patient procedure, de-risked with promising proof of concept data from a phase 1/2 clinical trial."
Proof of principle of MN01 demonstrated Phase 1/2 UCSF trial
A functional cure for Type I Diabetes which does not require systemic immunosuppressants or an invasive transplant procedure, plus built-in safety monitoring and kill switch functionalities.
